Fried food consumption associated with increased risk for heart failure
the ONA take:
According to preliminary findings presented at an American Heart Association meeting in Baltimore, Maryland, researchers from Harvard Medical School in Boston, Massachusetts, have found that fried foods are associated with an increased risk for heart failure.
For the study, researchers analyzed data from over 15,300 male doctors that participated in the Physicians' Health Study.
Participants completed food frequency questionnaires over a 3-year period, and during a mean follow-up of about 10 years, 632 participants developed heart failure.
Results showed that men who consumed fried food one to three times a week had an average 18% elevated risk of developing heart failure, while those who ate fried food four to six time a week had a 25% higher risk. Participants who ate fried foods seven times or more a week had a 68% higher risk of developing heart failure.
Although the study does not prove a cause-and-effect relationship between fried foods and heart failure, consuming fried foods increases calorie consumption, which in turn causes weight gain, hypertension, hyperlipidemia, and heart disease.
Furthermore, people who consume a lot of fried foods may be eating a less healthy diet with fewer vegetables, fruits, and beans.
Fried foods are associated with an increased risk for heart failure.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|